LifeMine Therapeutics Raises $263 Million To Advance LIFE-001 For Organ Transplantation
By Amit Chowdhry ● Aug 6, 2026
LifeMine Therapeutics has secured $263 million in financing to accelerate the clinical development of LIFE-001 and advance its broader pipeline of transplantation and immunology therapies. The financing includes an oversubscribed $188 million Series E round led by Milky Way Investments. New investors included Bezos Expeditions, Gates Frontier and RA Capital Management, while GV, LoLa Capital Partners, GlaxoSmithKline, Invus and ARCH Venture Partners continued their support.